




























































































Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
Information for England only. Dispensing contractors should note that from April 2021 the Drug Tariff will no longer be printed and distributed.
Typology: Exams
1 / 1224
This page cannot be seen from the preview
Don't miss anything!
1. In accordance with regulation 89(3) of the National Health Service (Pharmaceutical and Local Pharma- ceutical Services) Regulations 2013 (“the 2013 Regulations”), the Secretary of State for Health as re- spects England and in accordance with regulation 41(4) of the National Health Service (Pharmaceutical Services) (Wales) Regulations 2013, the Welsh Ministers* as respects Wales have amended the Drug Tariff and determinations made in respect of the amendments to the Drug Tariff shall have effect from 1 August 2015.
For England, by virtue of regulation 91(1) of the 2013 Regulations, the NHS Commissioning Board (“the Board”) has been appointed as a determining authority in relation to the pharmaceutical remuneration listed Schedule 8 to the 2013 Regulations (ie types of service remuneration) and remuneration for advanced services. This means that both the Secretary of State and the Board are able to determine remuneration in these areas, although if the Secretary of State determines remuneration in these areas, he is required to notify the Board of his intention to do so before doing so. As part of a phased transfer of responsibilities between the Secretary of State and the Board, the Board will be acting as the lead determining authority in relation to the following Parts:
By virtue of Part VIE, the Board is also a determining authority for England for the remuneration for enhanced services and acts as the lead determining authority in that area.
The Secretary of State is the sole determining authority for all other Parts.
Part XI, XIVD, XVIIID and XXI are rescinded in this edition of the Drug Tariff.
Before the Secretary of State, NHS Commissioning Board and the Welsh Ministers make further determinations they will consult with such organisations as appear to be representative of persons to whose remuneration the determination would relate and such other persons as they consider appropriate in respect of determinations which relate to persons providing pharmaceutical services, or a category of such services in accordance with section 165 of the National Health Service Act 2006 and section 89 of the National Health Service (Wales) Act 2006, regulations made under those sections and under section 164 of the National Health Service Act 2006 and section 88 of the National Health Service (Wales) Act 2006.
i) Effective date for all parts except those indicated in (ii) 1st day of the month
ii) Effective date for specific provisions in specified parts N/A
iii) Date of publication 1st day of the month
TO: General Medical Practitioners, Pharmacy Contractors, Appliance Contractors
2. Please note that you are now being supplied each month with the Drug Tariff which incorporates all amendments to date and this will continue until April 2021, when the Drug Tariff will no longer be printed and distributed (please see paragraph 4 for further information regarding these changes to the circulation of the Drug Tariff). All entries showing a change in price are not specifically included in this preface but are indicated in the Drug Tariff by L for price reduction and K for price increase; changes to the text re- lating to code, product description, or the inclusion of a new product are indicated by a vertical line in the margin. 3. While every effort is made to ensure that each monthly publication of the Drug Tariff includes all amendments made by the Secretary of State and the Welsh Ministers to the price applicable to the rele- vant period, the need to observe publishing deadlines sometimes defeats those efforts. Any omitted amendments will be effective from the date on which they came into force, even if publication of the details is unavoidably delayed.
S Special container
Co-dydramol 30mg/500mg tablets 56 Category A will be: 56 Category C Remedeine Forte Diazepam 5mg/2.5ml rectal solution tube 5 Category A will be: 5 Category C Desitin Pharma Ltd Ibuprofen 5% spray S 35ml Category C Ibuleve Speed Relief will be: S 35ml Category C Ibuleve Pain Relief
Contractors should note changes made to Transitional Payments (England only).
5.2 PART VIE - ENHANCED SERVICES (PHARMACY CONTRACTORS)
Contractors should note changes made to Determination of payments for enhanced services as regards England.
5.3 ADDITIONS TO JANUARY 2022 DRUG TARIFF
5.3.1 PART II - REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS
Individual Items Clindamycin 300mg capsules Clonazepam 500micrograms/5ml oral solution sugar free Clonidine 50micrograms/5ml oral solution sugar free
PAGE 26 Diazepam 2mg/5ml oral solution sugar free
PAGE 27 Doxepin 25mg capsules Dronedarone 400mg tablets
PAGE 29 Fresubin Thickened Level 2
PAGE 33 Midodrine 10mg tablets Mirtazapine 15mg/ml oral solution sugar free
PAGE 34 Nortriptyline 50mg tablets
PAGE 35 Ofloxacin 400mg tablets Olanzapine 20mg orodispersible tablets Ondansetron 4mg/5ml oral solution sugar free
PAGE 36 Pitolisant tablets (ALL)
PAGE 37 Promazine 50mg/5ml oral solution Propranolol 10mg/5ml oral solution sugar free
PAGE 38 Simple eye ointment SMA High Energy liquid
PAGE 39 Tamoxifen 10mg tablets
PAGE 40 Timolol 10mg tablets Trihexyphenidyl 5mg/5ml oral solution
Plantar Pressure Offloading Device
Marlen Healthcare Ltd
UltraMax Atlas Petal Shape Flat Closed pouch
UltraMax Atlas Petal Shape Shallow Convex Closed pouch
Marlen Healthcare Ltd
UltraMax Atlas Petal Shape Flat Drainable pouch
UltraMax Atlas Petal Shape Shallow Convex Drainable pouch
(A)(i) Nélaton Catheter ('ordinary' cylindrical Catheter) Pennine Healthcare Ltd
Wound Management Dressings Hydrogel Sheet Without Adhesive Border
Oakmed Ltd Option Connect 2
Dithranol 0.25% cream S 50 g 404 C Dithrocream
Dithranol 0.5% cream S 50 g 466 C Dithrocream
Dithranol 1% cream S 50 g 542 C Dithrocream
Mouthwash solution tablets S 100 1554 C Accord Healthcare Ltd
Pennine Pre-Lube catheter with integral PVC capsule containing lubragel pack of 10 (Male) (NC1608/FP-NC1616/FP) 8-16 995 (Male) (NC1608/BG/FP-NC1616/BG/FP) (including 1 litre integral bag)
(Female) (FC1608/FP-FC1616/FP) 8-16 995
Hydrosorb Square 10cm x 10cm 237 20cm x 20cm 711 Rectangular 5cm x 7.5cm 166
Compressana Calypso 70 Style Sizes Class 1 (10-17mmHg) Price per pair Below Knee Closed Toe I, II, III, IV, V, VI 1653 Thigh High Closed Toe I, II, III, IV, V 2170 Tights Closed Toe I, II, III, IV, V, VI 2686 Tights Queensize Closed Toe III, VI 2686
Compressana Calypso 140 Style Sizes Class 2 (15-18mmHg) Price per pair Below Knee Closed Toe I, II, III, IV, V, VI 1653 Thigh High Closed Toe I, II, III, IV, V 2170 Tights Closed Toe I, II, III, IV, V, VI 2686 Tights Queensize Closed Toe III, VI 2686
Colostomy with Filter and Soft Covering to both sides To fit up to 45mm Stoma JH600 30 4631
Oral Impact For preoperative nutritional support for patients who are malnourished or at risk of becoming malnourished.
5.5 OTHER CHANGES TO JANUARY 2022 DRUG TARIFF
5.5.1 PART II - REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS
Individual Items Trifluoperazine 1mg/5ml oral solution sugar free Now Reads Trifluoperazine oral solution sugar free (ALL)
5.5.2 PART VIIIA - BASIC PRICES OF DRUGS
Now Reads
Now Reads
Now Reads
Now Reads
S Special container
Buspirone 10mg tablets 30 3007 M
Buspirone 10mg tablets 30 2497 A
Buspirone 5mg tablets 30 516 M
Buspirone 5mg tablets 30 524 A
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment
S 30 g 1612 A
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment
S 30 g 779 M
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free
(12xS5)
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free
(12xS5)
Now Reads
Lancets - Sterile, Single-Use
Now Reads
Tracheostomy Breathing Aids Shiley Tracheostomy System
Sennosides 7.5mg/5ml oral solution sugar free
500 ml 699 C Senokot Pharmacy
Sennosides 7.5mg/5ml oral solution sugar free
500 ml 761 C Senokot Syrup 12 Years Plus
Q These product codes will change in the April 2022 Drug Tariff
TRUEplus Lancets (Trividia Health UK Ltd) (including products formerly listed under Nipro Diagnostics)
TRUEplus Lancets (Trividia Health UK Ltd)
Shiley Uncuffed Paediatric Tracheostomy tube 39 mm length Diam 3.0mm inner, 4.5mm outer 3.0PED 2970 40mm length Diam 3.5mm inner, 5.2mm outer 3.5PED 2970 41mm length Diam 4.0mm inner, 5.9mm outer 4.0PED 2970 42mm length Diam 4.5mm inner, 6.5mm outer 4.5PED 2970 44mm length Diam 5.0mm inner, 7.1mm outer 5.0PED 2970 45mm length Diam 5.5mm inner, 7.7mm outer 5.5PED 2970
Shiley Long Uncuffed Paediatric Tracheostomy tube 50mm length Diam 5.0mm inner, 7.1mm outer 5.0PDL 3245 52mm length Diam 5.5mm inner, 7.7mm outer 5.5PDL 3455 54mm length Diam 6.0mm inner, 8.3mm outer 6.0PDL 3455 56mm length Diam 6.5mm inner, 9.0mm outer 6.5PDL 3455
Shiley Cuffed Paediatric Tracheostomy tube 41mm length Diam 4.0mm inner, 5.9mm outer 4.0PDC 3444 42mm length Diam 4.5mm inner, 6.5mm outer 4.5PDC 3444 44mm length Diam 5.0mm inner, 7.1mm outer 5.0PDC 3444 46mm length Diam 5.5mm inner, 7.7mm outer 5.5PDC 3444
Shiley Long Cuffed Paediatric Tracheostomy tube 50mm length Diam 5.0mm inner, 7.1mm outer 5.0PLC 3455 52mm length Diam 5.5mm inner, 7.7mm outer 5.5PLC 3455 54mm length Diam 6.0mm inner, 8.3mm outer 6.0PLC 3455 56mm length Diam 6.5mm inner, 9.0mm outer 6.5PLC 3455
Shiley Low Pressure Cuffed Tracheostomy tube with reusable inner cannula 65mm length Diam 5.0mm inner, 9.4mm outer 4LPC 5429 76mm length Diam 7.0mm inner, 10.8mm outer 6LPC 5429 81mm length Diam 8.5mm inner, 12.2mm outer 8LPC 5429 81mm length Diam 9.0mm inner, 13.8mm outer 10LPC 5429
Now Reads
Now Reads
Now Reads
Q Shiley Uncuffed Paediatric Tracheostomy tube 39 mm length Diam 3.0mm inner, 4.5mm outer 3.0PED 2970 40mm length Diam 3.5mm inner, 5.2mm outer 3.5PED 2970 41mm length Diam 4.0mm inner, 5.9mm outer 4.0PED 2970 42mm length Diam 4.5mm inner, 6.5mm outer 4.5PED 2970 44mm length Diam 5.0mm inner, 7.1mm outer 5.0PED 2970 45mm length Diam 5.5mm inner, 7.7mm outer 5.5PED 2970
Q Shiley Long Uncuffed Paediatric Tracheostomy tube 50mm length Diam 5.0mm inner, 7.1mm outer 5.0PDL 3245 52mm length Diam 5.5mm inner, 7.7mm outer 5.5PDL 3455 54mm length Diam 6.0mm inner, 8.3mm outer 6.0PDL 3455 56mm length Diam 6.5mm inner, 9.0mm outer 6.5PDL 3455
Q Shiley Cuffed Paediatric Tracheostomy tube 41mm length Diam 4.0mm inner, 5.9mm outer 4.0PDC 3444 42mm length Diam 4.5mm inner, 6.5mm outer 4.5PDC 3444 44mm length Diam 5.0mm inner, 7.1mm outer 5.0PDC 3444 46mm length Diam 5.5mm inner, 7.7mm outer 5.5PDC 3444
Q Shiley Long Cuffed Paediatric Tracheostomy tube 50mm length Diam 5.0mm inner, 7.1mm outer 5.0PLC 3455 52mm length Diam 5.5mm inner, 7.7mm outer 5.5PLC 3455 54mm length Diam 6.0mm inner, 8.3mm outer 6.0PLC 3455 56mm length Diam 6.5mm inner, 9.0mm outer 6.5PLC 3455
Q Shiley Low Pressure Cuffed Tracheostomy tube with reusable inner cannula 65mm length Diam 5.0mm inner, 9.4mm outer 4LPC 5429 76mm length Diam 7.0mm inner, 10.8mm outer 6LPC 5429 81mm length Diam 8.5mm inner, 12.2mm outer 8LPC 5429 81mm length Diam 9.0mm inner, 13.8mm outer 10LPC 5429
Shiley Uncuffed Tracheostomy tube with reusable inner cannula 65mm length Diam 5.0mm inner, 9.4mm outer 4CFS 5237 76mm length Diam 6.4mm inner, 10.8mm outer 6CFS 5237 81mm length Diam 7.6mm inner, 12.2mm outer 8CFS 5237 81mm length Diam 8.9mm inner, 13.8mm outer 10CFS 5237
Q Shiley Uncuffed Tracheostomy tube with reusable inner cannula 65mm length Diam 5.0mm inner, 9.4mm outer 4CFS 5237 76mm length Diam 6.4mm inner, 10.8mm outer 6CFS 5237 81mm length Diam 7.6mm inner, 12.2mm outer 8CFS 5237 81mm length Diam 8.9mm inner, 13.8mm outer 10CFS 5237
Shiley Low Pressure Cuffed Tracheostomy tube with Disposable inner cannula 62mm length Diam 5.0mm inner, 9.4mm outer 4DCT 5237 74mm length Diam 6.4mm inner, 10.8mm outer 6DCT 5237 79mm length Diam 7.6mm inner, 12.2mm outer 8DCT 5237 79mm length Diam 8.9mm inner, 13.8mm outer 10DCT 5237
Q Shiley Low Pressure Cuffed Tracheostomy tube with Disposable inner cannula 62mm length Diam 5.0mm inner, 9.4mm outer 4DCT 5237 74mm length Diam 6.4mm inner, 10.8mm outer 6DCT 5237 79mm length Diam 7.6mm inner, 12.2mm outer 8DCT 5237 79mm length Diam 8.9mm inner, 13.8mm outer 10DCT 5237
This Page is Intentionally Blank
Definitions -
(a) Except where the context otherwise requires, the terms to which a meaning is assigned by the Regulations or the Terms of Service have the same meaning in this Tariff.
(b) The term ‘contractor’ has for Wales the same meaning as ‘chemist’ as defined in the National Health Service (Pharmaceutical Services) Regulations 1992 and for England the same meaning as ‘NHS chemist’ as defined in the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations
(c) A pharmacy contractor is a person with whom the NHS Commissioning Board (NHSCB) for England and Local Health Board (LHB) for Wales has made arrangements for the provision of pharmaceutical services in respect of the supply of drugs, appliances and chemical reagents.
(d) An appliance contractor is a person with whom the NHSCB for England and LHB for Wales has made arrangements for the provision of pharmaceutical services so far as it relates to the supply of appliances included within Part IXA/B/C of this Tariff.
(e) The term persons includes a body of persons corporate or unincorporate.
(f) The term Pricing Authority means, as the case may require, the NHS Business Services Authority (NHSBSA) or the NHS Wales Shared Services Partnership (NWSSP).
(g) The term appliances as used in this Tariff includes dressings.
(h) The term prescription refers to an item on a prescription form or dispensed in accordance with a repeatable prescription.
(i) The term prescription form includes, where appropriate, a repeatable prescription.
(j) The term pharmacy means any premises where drugs are provided by a pharmacist or pharmacy business as part of pharmaceutical services under section 126 (arrangements for pharmaceutical services) for England of the National Health Service Act 2006 and Section 80 of the National Health Service (Wales) Act
(k) Specials are unlicensed medicinal products manufactured in the UK for human use which have been specially prepared to meet a prescription ordered for individual patients without the need for the manufacturer to hold a marketing authorisation for the medicinal product concerned.
(l) Imported products are unlicensed medicinal products sourced from outside the UK under an importers licence issued by the MHRA. These products have been specially sourced to meet a prescription ordered for individual patients without the need for the importer to hold a marketing authorisation for the medicinal product concerned.
In the preparation of this Tariff the Secretary of State for Health and the Welsh Ministers have consulted the Pharmaceutical Services Negotiating Committee.
Part I - Requirements for the Supply of Drugs, Appliances and Chemical Reagents
CLAUSE 1 DRUGS Any drug included in this Tariff or in the British National Formulary including the Nurse Prescribers' Formulary, Dental Practitioner's Formulary, European Pharmacopoeia, British Pharmacopoeia or the British Pharmaceutical Codex, supplied as part of pharmaceutical services, must comply with the standard or formula specified therein unless the prescriber has indicated to the contrary. Any drug supplied which is not so included must be of a grade or quality not lower than that ordinarily used for medicinal purposes.
CLAUSE 2 APPLIANCES The only appliances which may be supplied as part of the pharmaceutical services are those listed in Part IXA/ B/C, and Part X (see Clause 4 below), of the Tariff and which comply with the specifications therein. The items within Part IXA which are not prescribable on Forms FP10(CN) and FP10(PN) are annotated 2
CLAUSE 3 CHEMICAL REAGENTS The only chemical reagents which may be supplied as part of the pharmaceutical services are those listed in Part IXR of the Tariff. The items within Part IXR which are not prescribable on forms FP10(CN) and FP10(PN) are annotated 2
CLAUSE 4 DOMICILIARY OXYGEN THERAPY SERVICE The requirements for the supply of domiciliary oxygen and its associated appliances together with the arrangements for reimbursement of those contractors included on the CCG’s for England and LHB's for Wales lists of contractors authorised to provide this service, are set out in Part X of the Tariff.
CLAUSE 5 PAYMENTS FOR PROVIDING PHARMACEUTICAL SERVICES
CLAUSE 5A CLAIMS FOR PAYMENTS
Claims for payment for Wales and England (for England only up until March 2022 (February 2022 prescriptions))
(a) Endorse prescription forms 1 as required in Clause 9 (Endorsement Requirements) of this Tariff; and
(b) Dispatch the prescription forms to the relevant division of the NHS Business Service Authority: NHS Prescription Services for England, or Primary Care Services (PCS) for Wales: (i) with the appropriate claim form (also referred to as the FP34C form^2 ); (ii) sorted as appropriate; (iii) in a secure manner that enables tracking and tracing of the delivery; and (iv) not later than the 5th day of the month following that in which the supply was made^3.
(^1) For the purpose of Part I of the Drug Tariff, wherever prescriptions, prescription forms or batch issues are
mentioned, this includes prescription forms where supply was made in accordance with a Serious Shortage Protocol (SSP).
(^2) Contractors should note that the FP34C is available online on the Manage Your Service (MYS) portal and in
paper form. However, from April 2022 the form will be available online only. Contractors, who use the MYS portal, must print off the populated FP34C from the portal and dispatch it alongside the batch of paper prescriptions.
(^3) Where one or more bank holiday occurs within the first five days of the month, dispatch must be secured by
the 6th of that month. Note: for contractors, who use the FP34C on MYS, they must complete and submit it by the 6th of the month including where needed printing the populated FP34C and dispatching it alongside the batch of paper prescriptions.
(a) endorse batch issues as required in Clause 9 (Endorsement Requirements) of this Tariff. In addition, batch issues relating to drugs, appliances or chemical reagents which have been dispensed must be stamped with the contractor's stamp and dated with the date on which the items were dispensed.
(b) dispatch the batch issues (in the same parcel as per Clause 5A 1) relating to drugs, appliances or chemical reagents which have been dispensed to the NHS Prescription Services for England or PCS for Wales: